266 related articles for article (PubMed ID: 2912564)
1. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
Kooistra KL; Rodriguez M; Powis G
Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
[TBL] [Abstract][Full Text] [Related]
2. Topical chemotherapy of intradermal Walker 256 carcinosarcoma with diaziquone and doxorubicin in the rat.
Moore DJ; Powis G; Richardson RL; Pittelkow MR
Cancer Res; 1985 Nov; 45(11 Pt 1):5466-72. PubMed ID: 4053022
[TBL] [Abstract][Full Text] [Related]
3. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.
Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER
Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551
[TBL] [Abstract][Full Text] [Related]
4. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
[TBL] [Abstract][Full Text] [Related]
6. [Intrathecal ACNU against malignant leptomeningeal tumors--toxicity and therapeutic effect in experimental animals].
Nagatani M; Arita N; Ushio Y; Hayakawa T; Tzuu-Yuan H; Yoshimine T; Mori S; Mogami H
No To Shinkei; 1986 Nov; 38(11):1071-5. PubMed ID: 3468960
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal ACNU against experimental leptomeningeal tumors.
Huang TY; Howng SL
Kaohsiung J Med Sci; 1997 Oct; 13(10):626-30. PubMed ID: 9385779
[TBL] [Abstract][Full Text] [Related]
8. [Intrathecal ACNU for the treatment of a meningeal gliomatosis model].
Yoshida T; Shimizu K; Mogami H; Egawa T; Sakamoto Y
Gan To Kagaku Ryoho; 1987 Jan; 14(1):84-90. PubMed ID: 3467657
[TBL] [Abstract][Full Text] [Related]
9. Effect of MX2, a new morpholino anthracycline, against experimental brain tumors.
Izumoto S; Arita N; Hayakawa T; Ohnishi T; Taki T; Yamamoto H; Ushio Y
Anticancer Res; 1990; 10(3):735-9. PubMed ID: 2369088
[TBL] [Abstract][Full Text] [Related]
10. Augmentation of the effect of doxorubicin with low-dose tumor necrosis factor in experimental liver metastasis.
Bloom ND; Norbergs DA; Sherman B; Sadjadi M; Ramaswamy G; Jacobs R; Ackerman N
Mol Biother; 1990 Jun; 2(2):121-4. PubMed ID: 2363856
[TBL] [Abstract][Full Text] [Related]
11. Alteration of blood-CSF barrier by tumor invasion into the meninges.
Ushio Y; Shimizu K; Aragaki Y; Arita N; Hayakawa T; Mogami H
J Neurosurg; 1981 Sep; 55(3):445-9. PubMed ID: 6943305
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal 5-fluoro-2'-deoxyuridine (FdUrd) for the treatment of solid tumor neoplastic meningitis: an in vivo study.
Nakagawa H; Yamada M; Fukushima M; Ikenaka K
Cancer Chemother Pharmacol; 1999; 43(3):247-56. PubMed ID: 9923556
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
Keller HJ; Keppler B; Schmähl D
Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
[TBL] [Abstract][Full Text] [Related]
14. Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis.
Fuchs HE; Archer GE; Colvin OM; Bigner SH; Schuster JM; Fuller GN; Muhlbaier LH; Schold SC; Friedman HS; Bigner DD
Cancer Res; 1990 Mar; 50(6):1954-9. PubMed ID: 2306744
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal gene therapy for malignant leptomeningeal neoplasia.
Ram Z; Walbridge S; Oshiro EM; Viola JJ; Chiang Y; Mueller SN; Blaese RM; Oldfield EH
Cancer Res; 1994 Apr; 54(8):2141-5. PubMed ID: 8174120
[TBL] [Abstract][Full Text] [Related]
16. [In vitro study on intrathecal application of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant tumor].
Nakagawa H; Yamada M; Fukushima M; Shimizu K; Ikenaka K
No Shinkei Geka; 1998 Sep; 26(9):787-94. PubMed ID: 9757455
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of a rat meningeal gliomatosis model with neocarzinostatin].
Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y; Egawa T
No To Shinkei; 1987 Jul; 39(7):615-9. PubMed ID: 2960332
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats.
Shimizu K; Ushio Y; Hayakawa T; Mogami H
Cancer Res; 1980 Apr; 40(4):1341-3. PubMed ID: 6153573
[TBL] [Abstract][Full Text] [Related]
19. Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.
Gold J
Cancer Biochem Biophys; 1978; 3(1):41-5. PubMed ID: 552898
[TBL] [Abstract][Full Text] [Related]
20. [Enhancement of Walker-256 antitumor effect by intra-arterial administration of TNF before using mitomycin C].
Sato T; Sekine S; Katsumi S
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2392-5. PubMed ID: 3137875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
